Inspire Medical Systems Inc (N:INSP)

Business Focus: Medical Devices & Implants

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 5500 Wayzata Blvd Ste 1600
Tel: N/A
IR: See website
Key People
Marilyn Carlson Nelson
Independent Chairman of the Board
Timothy P. Herbert
President, Chief Executive Officer, Director
Richard Buchholz
Chief Financial Officer
Randy Ban
Senior Vice President, Global Sales and Marketing
Steven Jandrich
Chief Compliance Officer, Vice President of Human Resources
Business Overview
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the developing and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. The Company has developed a novel, closed-loop solution that continuously monitors a patient's breathing patterns and delivers mild hypoglossal nerve stimulation to maintain an open airway. The system delivers mild stimulation to the hypoglossal nerve, which controls the movement of user's tongue and other key airway muscles. By stimulating these muscles, the airway remains open during sleep. The system is controlled by a small handheld sleep remote.
Financial Overview
For the three months ended 31 March 2019, Inspire Medical Systems Inc revenues increased 62% to $16.3M. Net loss increased 27% to $8.3M. Revenues reflect United States segment increase of 64% to $14.4M, Europe segment increase of 46% to $1.9M. Higher net loss reflects General and administrative - Balancing increase from $1.3M to $18.4M (expense), Stock-Based Compensation in General and increase from $28K to $1.2M (expense).
Employees: 165 as of Dec 31, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $1,446M as of Mar 31, 2019
Annual revenue (TTM): $56.80M as of Mar 31, 2019
EBITDA (TTM): -$23.55M as of Mar 31, 2019
Net annual income (TTM): -$23.59M as of Mar 31, 2019
Free cash flow (TTM): -$23.74M as of Mar 31, 2019
Net Debt Last Fiscal Year: N/A
Shares outstanding: 23,805,187 as of Apr 30, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization